Abstract
Respiratory immunity is responsible for pathogen elimination and prevention of chronic inflammation through both innate and adaptive mechanisms. Inappropriate activation of these immune systems in the respiratory mucosa results in chronic inflammatory airways disease such as asthma. Adaptive immunity is stimulated for example by allergen exposure that activates T and B lymphocytes leading to IgE production and influx of eosinophilic granulocytes into the airways. Presence of IgE and eosinophilia are diagnostic hallmarks as well as key pathogenic components that have been utilized in the search for improved therapies of allergic asthma for the past several decades. The recent breakthroughs in successful clinical application of biologicals in asthma were driven by improved genetic, biochemical, and immunological screening methods, novel imaging and bioinformatics technology, biomarker discovery and a better understanding of immune regulation of allergic airway inflammation. In this chapter we discuss our current understanding of immune regulation of airway inflammation in asthma, with a special focus on the interactions between the adaptive and innate immune systems and the epithelial mucosal tissue.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Bostock J (1819) Case of a periodical affection of the eyes and chest. Med Chir Trans 10:161–165
Shulman ST (2016) Clemens von Pirquet: a remarkable life and career. J Pediatric Infect Dis Soc. https://doi.org/10.1093/jpids/piw063
Silverstein A, Clemens M (2000) Freiherr von Pirquet: explaining immune complex disease in 1906. Nat Immunol 1:453–455. https://doi.org/10.1038/82691
Ring J, Gutermuth J (2011) 100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT). Allergy 66:713–724. https://doi.org/10.1111/j.1398-9995.2010.02541.x
Johansson SGO (2016) The discovery of IgE. J Allergy Clin Immunol 137:1671–1673. https://doi.org/10.1016/j.jaci.2016.04.004
Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348–2357
Robinson DS et al (1992) Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 326:298–304. https://doi.org/10.1056/NEJM199201303260504
Cousins DJ, McDonald J, Lee TH (2008) Therapeutic approaches for control of transcription factors in allergic disease. J Allergy Clin Immunol 121:803–809; quiz 810–801. doi:https://doi.org/10.1016/j.jaci.2008.02.008
Corrigan CJ et al (1996) Glucocorticoid resistant asthma: T-lymphocyte steroid metabolism and sensitivity to glucocorticoids and immunosuppressive agents. Eur Respir J 9:2077–2086
Corrigan CJ (1996) Glucocorticoid-resistant asthma. T-lymphocyte defects. Am J Respir Crit Care Med 154:S53–S55; discussion S55–S57. doi:https://doi.org/10.1164/ajrccm/154.2_Pt_2.S53
Haczku A et al (1994) The effect of dexamethasone, cyclosporine, and rapamycin on T-lymphocyte proliferation in vitro: comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid-resistant chronic asthma. J Allergy Clin Immunol 93:510–519
Corrigan CJ et al (1991) Glucocorticoid resistance in chronic asthma. Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A. Am Rev Respir Dis 144:1026–1032. https://doi.org/10.1164/ajrccm/144.5.page
Corrigan CJ et al (1991) Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. Am Rev Respir Dis 144:1016–1025. https://doi.org/10.1164/ajrccm/144.5.1016
Radauer C et al (2014) Update of the WHO/IUIS Allergen Nomenclature Database based on analysis of allergen sequences. Allergy 69:413–419
Mueller GA (2017) Contributions and future directions for structural biology in the study of allergens. Int Arch Allergy Immunol 174:57–66. https://doi.org/10.1159/000481078
Breiteneder H, Radauer C (2004) A classification of plant food allergens. J Allergy Clin Immunol 113:821–830; quiz 831, doi:https://doi.org/10.1016/j.jaci.2004.01.779
Radauer C (2017) Navigating through the jungle of allergens: features and applications of allergen databases. Int Arch Allergy Immunol 173:1–11. https://doi.org/10.1159/000471806
Nadel JA (1988) Role of airway epithelial cells in the defense of airways. Prog Clin Biol Res 263:331–339
Holgate ST (2007) Epithelium dysfunction in asthma. J Allergy Clin Immunol 120:1233–1244; quiz 1245–1236. doi:https://doi.org/10.1016/j.jaci.2007.10.025
Hammad H, Lambrecht BN (2015) Barrier epithelial cells and the control of type 2 immunity. Immunity 43:29–40. https://doi.org/10.1016/j.immuni.2015.07.007
Golebski K et al (2013) The multi-faceted role of allergen exposure to the local airway mucosa. Allergy 68:152–160. https://doi.org/10.1111/all.12080
Muller L, Jaspers I (2012) Epithelial cells, the “switchboard” of respiratory immune defense responses: effects of air pollutants. Swiss Med Wkly 142:w13653. https://doi.org/10.4414/smw.2012.13653
Waters CM, Roan E, Navajas D (2012) Mechanobiology in lung epithelial cells: measurements, perturbations, and responses. Compr Physiol 2:1–20. https://doi.org/10.1002/cphy.c100090
Hammad H, Lambrecht BN (2011) Dendritic cells and airway epithelial cells at the interface between innate and adaptive immune responses. Allergy 66:579–587. https://doi.org/10.1111/j.1398-9995.2010.02528.x
Lambrecht BN, Hammad H (2010) The role of dendritic and epithelial cells as master regulators of allergic airway inflammation. Lancet 376:835–843. https://doi.org/10.1016/S0140-6736(10)61226-3
Rock JR, Randell SH, Hogan BL (2010) Airway basal stem cells: a perspective on their roles in epithelial homeostasis and remodeling. Dis Model Mech 3:545–556. https://doi.org/10.1242/dmm.006031
Bourdin A, Gras D, Vachier I, Chanez P (2009) Upper airway x 1: allergic rhinitis and asthma: united disease through epithelial cells. Thorax 64:999–1004. https://doi.org/10.1136/thx.2008.112862
Crystal RG, Randell SH, Engelhardt JF, Voynow J, Sunday ME (2008) Airway epithelial cells: current concepts and challenges. Proc Am Thorac Soc 5:772–777. https://doi.org/10.1513/pats.200805-041HR
Wang Y, Bai C, Li K, Adler KB, Wang X (2008) Role of airway epithelial cells in development of asthma and allergic rhinitis. Respir Med 102:949–955. https://doi.org/10.1016/j.rmed.2008.01.017
Prefontaine D, Hamid Q (2007) Airway epithelial cells in asthma. J Allergy Clin Immunol 120:1475–1478. https://doi.org/10.1016/j.jaci.2007.09.041
Chiba T et al (2007) Possible novel receptor for PGD2 on human bronchial epithelial cells. Int Arch Allergy Immunol 143(Suppl 1):23–27. https://doi.org/10.1159/000101400
Upham JW, Stick SM (2006) Interactions between airway epithelial cells and dendritic cells: implications for the regulation of airway inflammation. Curr Drug Targets 7:541–545
Campbell AM (1997) Bronchial epithelial cells in asthma. Allergy 52:483–489
Maazi H, Akbari O (2017) Type two innate lymphoid cells: the Janus cells in health and disease. Immunol Rev 278:192–206. https://doi.org/10.1111/imr.12554
Kubo M (2017) Innate and adaptive type 2 immunity in lung allergic inflammation. Immunol Rev 278:162–172. https://doi.org/10.1111/imr.12557
Hoffmann F et al (2016) Origin, localization, and immunoregulatory properties of pulmonary phagocytes in allergic asthma. Front Immunol 7:107. https://doi.org/10.3389/fimmu.2016.00107
Cook PC, MacDonald AS (2016) Dendritic cells in lung immunopathology. Semin Immunopathol 38:449–460. https://doi.org/10.1007/s00281-016-0571-3
Hirota JA, Knight DA (2012) Human airway epithelial cell innate immunity: relevance to asthma. Curr Opin Immunol 24:740–746
Deban L, Jaillon S, Garlanda C, Bottazzi B, Mantovani A (2011) Pentraxins in innate immunity: lessons from PTX3. Cell Tissue Res 343:237–249. https://doi.org/10.1007/s00441-010-1018-0
Garred P, Honore C, Ma YJ, Munthe-Fog L, Hummelshoj T (2009) MBL2, FCN1, FCN2 and FCN3-The genes behind the initiation of the lectin pathway of complement. Mol Immunol 46:2737–2744. https://doi.org/10.1016/j.molimm.2009.05.005
Iwasaki A, Medzhitov R (2010) Regulation of adaptive immunity by the innate immune system. Science 327:291–295. https://doi.org/10.1126/science.1183021
Schleimer RP, Kato A, Kern R, Kuperman D, Avila PC (2007) Epithelium: at the interface of innate and adaptive immune responses. J Allergy Clin Immunol 120:1279–1284. https://doi.org/10.1016/j.jaci.2007.08.046
Walport M, Complement J (2001) First of two parts. N Engl J Med 344:1058–1066. https://doi.org/10.1056/NEJM200104053441406
Manfredi AA, Rovere-Querini P, Bottazzi B, Garlanda C, Mantovani A (2008) Pentraxins, humoral innate immunity and tissue injury. Curr Opin Immunol 20:538–544. https://doi.org/10.1016/j.coi.2008.05.004
Gakhar L et al (2010) PLUNC is a novel airway surfactant protein with anti-biofilm activity. PLoS One 5:e9098. https://doi.org/10.1371/journal.pone.0009098
Kool M et al (2011) An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma. Immunity 34:527–540. doi:S1074-7613(11)00122-1 [pii] https://doi.org/10.1016/j.immuni.2011.03.015
Kouzaki H, Iijima K, Kobayashi T, O’Grady SM, Kita H (2011) The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses. J Immunol 186:4375–4387. doi:jimmunol.1003020 [pii] https://doi.org/10.4049/jimmunol.1003020
Shaw MH, Reimer T, Kim YG, Nunez G (2008) NOD-like receptors (NLRs): bona fide intracellular microbial sensors. Curr Opin Immunol 20:377–382. https://doi.org/10.1016/j.coi.2008.06.001
Modlin RL (2012) Innate immunity: ignored for decades, but not forgotten. J Invest Dermatol 132:882–886. https://doi.org/10.1038/jid.2011.373
Kawai T, Akira S (2007) TLR signaling. Semin Immunol 19:24–32. https://doi.org/10.1016/j.smim.2006.12.004
Lee MS, Kim YJ (2007) Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu Rev Biochem 76:447–480. https://doi.org/10.1146/annurev.biochem.76.060605.122847
Cambi A, Figdor CG (2005) Levels of complexity in pathogen recognition by C-type lectins. Curr Opin Immunol 17:345–351. https://doi.org/10.1016/j.coi.2005.05.011
Lan RS, Stewart GA, Henry PJ (2002) Role of protease-activated receptors in airway function: a target for therapeutic intervention? Pharmacol Ther 95:239–257
Vinhas R et al (2011) Pollen proteases compromise the airway epithelial barrier through degradation of transmembrane adhesion proteins and lung bioactive peptides. Allergy 66:1088–1098. https://doi.org/10.1111/j.1398-9995.2011.02598.x
Page K, Hughes VS, Bennett GW, Wong HR (2006) German cockroach proteases regulate matrix metalloproteinase-9 in human bronchial epithelial cells. Allergy 61:988–995. https://doi.org/10.1111/j.1398-9995.2006.01103.x
Tai HY et al (2006) Pen ch 13 allergen induces secretion of mediators and degradation of occludin protein of human lung epithelial cells. Allergy 61:382–388. https://doi.org/10.1111/j.1398-9995.2005.00958.x
Yike I (2011) Fungal proteases and their pathophysiological effects. Mycopathologia 171:299–323. https://doi.org/10.1007/s11046-010-9386-2
Mathews JA et al (2011) A potential new target for asthma therapy: a disintegrin and metalloprotease 10 (ADAM10) involvement in murine experimental asthma. Allergy 66:1193–1200. https://doi.org/10.1111/j.1398-9995.2011.02614.x
Wan H et al (1999) Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin Invest 104:123–133. https://doi.org/10.1172/JCI5844
Carr MJ, Schechter NM, Undem BJ (2000) Trypsin-induced, neurokinin-mediated contraction of guinea pig bronchus. Am J Respir Crit Care Med 162:1662–1667. https://doi.org/10.1164/ajrccm.162.5.9912099
de Boer JD, Majoor CJ, van ‘t Veer C, Bel EH, van der Poll T (2012) Asthma and coagulation. Blood 119:3236–3244. https://doi.org/10.1182/blood-2011-11-391532
Endo, Y., Matsushita, M. & Fujita, T. Role of ficolin in innate immunity and its molecular basis. Immunobiology 212, 371-379, doi:https://doi.org/10.1016/j.imbio.2006.11.014 (2007)
Holmskov U, Thiel S, Jensenius JC (2003) Collections and ficolins: humoral lectins of the innate immune defense. Annu Rev Immunol 21:547–578. https://doi.org/10.1146/annurev.immunol.21.120601.140954
Holmskov UL (2000) Collectins and collectin receptors in innate immunity. APMIS Suppl 100:1–59
Shpacovitch V, Feld M, Hollenberg MD, Luger TA, Steinhoff M (2008) Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity. J Leukoc Biol 83:1309–1322. https://doi.org/10.1189/jlb.0108001
Sudha VT, Arora N, Gaur SN, Pasha S, Singh BP (2008) Identification of a serine protease as a major allergen (Per a 10) of Periplaneta americana. Allergy 63:768–776. https://doi.org/10.1111/j.1398-9995.2007.01602.x
Togbe D et al (2013) Thymic stromal lymphopoietin enhances Th2/Th22 and reduces IL-17A in protease-allergen-induced airways inflammation. ISRN Allergy 2013:971036. https://doi.org/10.1155/2013/971036
Page K (2012) Role of cockroach proteases in allergic disease. Curr Allergy Asthma Rep 12:448–455. https://doi.org/10.1007/s11882-012-0276-1
Matsuwaki Y, Wada K, Moriyama H, Kita H (2011) Human eosinophil innate response to Alternaria fungus through protease-activated receptor-2. Int Arch Allergy Immunol 155(Suppl 1):123–128. https://doi.org/10.1159/000327498
Ebeling C et al (2005) Proteinase-activated receptor 2 activation in the airways enhances antigen-mediated airway inflammation and airway hyperresponsiveness through different pathways. J Allergy Clin Immunol 115:623–630. doi:S0091674904031203 [pii] https://doi.org/10.1016/j.jaci.2004.11.042
Reed CE, Kita H (2004) The role of protease activation of inflammation in allergic respiratory diseases. J Allergy Clin Immunol 114:997–1008.; quiz 1009. https://doi.org/10.1016/j.jaci.2004.07.060
D’Agostino B et al (2007) Activation of protease-activated receptor-2 reduces airways inflammation in experimental allergic asthma. Clin Exp Allergy 37:1436–1443. https://doi.org/10.1111/j.1365-2222.2007.02793.x
Hammad H et al (2010) Inflammatory dendritic cells--not basophils--are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen. J Exp Med 207:2097–2111. doi:jem.20101563 [pii] https://doi.org/10.1084/jem.20101563
Wang Q et al (2009) Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses. J Immunol 183:6989–6997. doi:jimmunol.0901386 [pii] https://doi.org/10.4049/jimmunol.0901386
Trompette A et al (2009) Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature 457:585–588. doi:nature07548 [pii] https://doi.org/10.1038/nature07548
Rigaux P et al (2009) Immunomodulatory properties of Lactobacillus plantarum and its use as a recombinant vaccine against mite allergy. Allergy 64:406–414. https://doi.org/10.1111/j.1398-9995.2008.01825.x
Hammad H et al (2009) House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat Med 15:410–416, doi:nm.1946 [pii] https://doi.org/10.1038/nm.1946
Lam D, Ng N, Lee S, Batzer G, Horner AA (2008) Airway house dust extract exposures modify allergen-induced airway hypersensitivity responses by TLR4-dependent and independent pathways. J Immunol 181:2925–2932. doi:181/4/2925 [pii]
Kato A, Favoreto S Jr, Avila PC, Schleimer RP (2007) TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells. J Immunol 179:1080–1087
Sha Q, Truong-Tran AQ, Plitt JR, Beck LA, Schleimer RP (2004) Activation of airway epithelial cells by toll-like receptor agonists. Am J Respir Cell Mol Biol 31:358–364. https://doi.org/10.1165/rcmb.2003-0388OC
Liu, AH (2002) Endotoxin exposure in allergy and asthma: reconciling a paradox. J Allergy Clin Immunol 109:379–392. doi:S0091674902085688 [pii]
Lambrecht BN, Hammad H (2012) The airway epithelium in asthma. Nat Med 18:684–692. doi:nm.2737 [pii] https://doi.org/10.1038/nm.2737
Ryu JH et al (2013) Distinct TLR-mediated pathways regulate house dust mite-induced allergic disease in the upper and lower airways. J Allergy Clin Immunol 131:549–561. https://doi.org/10.1016/j.jaci.2012.07.050
Holtzman MJ et al (2009) Immune pathways for translating viral infection into chronic airway disease. Adv Immunol 102:245–276. doi:S0065-2776(09)01205-X [pii] https://doi.org/10.1016/S0065-2776(09)01205-X
Gavala ML, Bertics PJ, Gern JE (2011) Rhinoviruses, allergic inflammation, and asthma. Immunol Rev 242:69–90. https://doi.org/10.1111/j.1600-065X.2011.01031.x
See H, Wark P (2008) Innate immune response to viral infection of the lungs. Paediatr Respir Rev 9:243–250
Hsu AC, See HV, Hansbro PM, Wark PA (2012) Innate immunity to influenza in chronic airways diseases. Respirology 17:1166–1175. https://doi.org/10.1111/j.1440-1843.2012.02200.x
Chang YJ et al (2011) Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 12:631–638, doi:ni.2045 [pii] https://doi.org/10.1038/ni.2045
Mastrangelo P, Hegele RG (2013) RSV fusion: time for a new model. Virus 5:873–885. https://doi.org/10.3390/v5030873
Terajima M et al (1997) Rhinovirus infection of primary cultures of human tracheal epithelium: role of ICAM-1 and IL-1beta. Am J Phys 273:L749–L759
Bianco A, Spiteri MA (1998) A biological model to explain the association between human rhinovirus respiratory infections and bronchial asthma. Monaldi Arch Chest Dis 53:83–87
Papi A et al (2013) Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor kappaB and c-Jun N-terminal kinase activation. J Allergy Clin Immunol. https://doi.org/10.1016/j.jaci.2013.05.028
Sykes A et al (2013) TLR3, TLR4 and TLRs7-9 induced interferons are not impaired in airway and blood cells in well controlled asthma. PLoS One 8:e65921. https://doi.org/10.1371/journal.pone.0065921
Slater L et al (2010) Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium. PLoS Pathog 6:e1001178. https://doi.org/10.1371/journal.ppat.1001178
Contoli M et al (2006) Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 12:1023–1026. https://doi.org/10.1038/nm1462
Monticelli LA et al (2011) Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 12:1045–1054. https://doi.org/10.1031/ni.2131
Bartemes KR, Kita H (2012) Dynamic role of epithelium-derived cytokines in asthma. Clin Immunol 143:222–235. doi:S1521-6616(12)00085-X [pii] https://doi.org/10.1016/j.clim.2012.03.001
Fort MM et al (2001) IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15:985–995. doi:S1074–7613(01)00243–6 [pii]
Schmitz J et al (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23:479–490. doi:S1074-7613(05)00311-0 [pii] https://doi.org/10.1016/j.immuni.2005.09.015
Zhou B et al (2005) Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat Immunol 6:1047–1053. doi:ni1247 [pii] https://doi.org/10.1038/ni1247
Oboki K et al (2010) IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Natl Acad Sci U S A 107:18581–18586. https://doi.org/10.1073/pnas.1003059107
Perros F, Hoogsteden HC, Coyle AJ, Lambrecht BN, Hammad H (2009) Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC-derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation. Allergy 64:995–1002. doi:ALL2095 [pii] https://doi.org/10.1111/j.1398-9995.2009.02095.x
Schutyser E, Struyf S, Van Damme J (2003) The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev 14:409–426
Onishi RM, Gaffen SL (2010) Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 129:311–321. https://doi.org/10.1111/j.1365-2567.2009.03240.x
Park H et al (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6:1133–1141. doi:ni1261 [pii] https://doi.org/10.1038/ni1261
Alcorn JF, Crowe CR, Kolls JK (2010) TH17 cells in asthma and COPD. Annu Rev Physiol 72:495–516. https://doi.org/10.1146/annurev-physiol-021909-135926
Lajoie S et al (2010) Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat Immunol 11:928–935. doi:ni.1926 [pii] https://doi.org/10.1038/ni.1926
Schnyder-Candrian S et al (2006) Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med 203:2715–2725. doi:jem.20061401 [pii] https://doi.org/10.1084/jem.20061401
Gudbjartsson DF et al (2009) Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 41:342–347. https://doi.org/10.1038/ng.323
Moffatt MF et al (2010) A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 363:1211–1221. https://doi.org/10.1056/NEJMoa0906312
Hunninghake GM et al (2010) TSLP polymorphisms are associated with asthma in a sex-specific fashion. Allergy 65:1566–1575. https://doi.org/10.1111/j.1398-9995.2010.02415.x
Ober C, Yao TC (2011) The genetics of asthma and allergic disease: a 21st century perspective. Immunol Rev 242:10–30. https://doi.org/10.1111/j.1600-065X.2011.01029.x
Karmaus W, Ziyab AH, Everson T, Holloway JW (2013) Epigenetic mechanisms and models in the origins of asthma. Curr Opin Allergy Clin Immunol 13:63–69. https://doi.org/10.1097/ACI.0b013e32835ad0e7
Sofer T et al (2013) Exposure to airborne particulate matter is associated with methylation pattern in the asthma pathway. Epigenomics 5:147–154. https://doi.org/10.2217/epi.13.16
Chen W et al (2013) ADCYAP1R1 and asthma in Puerto Rican children. Am J Respir Crit Care Med 187:584–588. https://doi.org/10.1164/rccm.201210-1789OC
Reinius LE et al (2013) DNA methylation in the Neuropeptide S Receptor 1 (NPSR1) promoter in relation to asthma and environmental factors. PLoS One 8:e53877. https://doi.org/10.1371/journal.pone.0053877
Hammad H, Lambrecht BN (2008) Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat Rev Immunol 8:193–204. https://doi.org/10.1038/nri2275
Reibman J, Hsu Y, Chen LC, Bleck B, Gordon T (2003) Airway epithelial cells release MIP-3alpha/CCL20 in response to cytokines and ambient particulate matter. Am J Respir Cell Mol Biol 28:648–654. https://doi.org/10.1165/rcmb.2002-0095OC
Haczku A (2012) The dendritic cell niche in chronic obstructive pulmonary disease. Respir Res 13:80. https://doi.org/10.1186/1465-9921-13-80
Lukacs NW, Prosser DM, Wiekowski M, Lira SA, Cook DN (2001) Requirement for the chemokine receptor CCR6 in allergic pulmonary inflammation. J Exp Med 194:551–555
Phadke AP, Akangire G, Park SJ, Lira SA, Mehrad B (2007) The role of CC chemokine receptor 6 in host defense in a model of invasive pulmonary aspergillosis. Am J Respir Crit Care Med 175:1165–1172. https://doi.org/10.1164/rccm.200602-256OC
Soumelis V et al (2002) Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3:673–680. https://doi.org/10.1038/ni805
Ito T et al (2005) TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med 202:1213–1223. https://doi.org/10.1084/jem.20051135
Wang YH et al (2006) Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells. Immunity 24:827–838. https://doi.org/10.1016/j.immuni.2006.03.019
Omori M, Ziegler S (2007) Induction of IL-4 expression in CD4(+) T cells by thymic stromal lymphopoietin. J Immunol 178:1396–1404
Wang YH et al (2007) IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exp Med 204:1837–1847. https://doi.org/10.1084/jem.20070406
Moreira AP, Hogaboam CM (2011) Macrophages in allergic asthma: fine-tuning their pro- and anti-inflammatory actions for disease resolution. J Interf Cytokine Res 31:485–491. https://doi.org/10.1089/jir.2011.0027
Boorsma CE, Draijer C, Melgert BN (2013) Macrophage heterogeneity in respiratory diseases. Mediat Inflamm 2013:769214. https://doi.org/10.1155/2013/769214
Martinez FO, Sica A, Mantovani A, Locati M (2008) Macrophage activation and polarization. Front Biosci 13:453–461
Chistiakov DA et al (2015) Macrophage phenotypic plasticity in atherosclerosis: the associated features and the peculiarities of the expression of inflammatory genes. Int J Cardiol 184:436–445. https://doi.org/10.1016/j.ijcard.2015.03.055
Jiang Z, Zhu L (2016) Update on the role of alternatively activated macrophages in asthma. J Asthma Allergy 9:101–107. https://doi.org/10.2147/JAA.S104508
Muraille E, Leo O, Moser M (2014) Th1/Th2 paradigm extended: macrophage polarization as an unappreciated pathogen-driven escape mechanism? Front Immunol 5:603. https://doi.org/10.3389/fimmu.2014.00603
Draijer C, Robbe P, Boorsma CE, Hylkema MN, Melgert BN (2013) Characterization of macrophage phenotypes in three murine models of house-dust-mite-induced asthma. Mediat Inflamm 2013:10. https://doi.org/10.1155/2013/632049
Joshi AD et al (2010) Interleukin-33 contributes to both M1 and M2 chemokine marker expression in human macrophages. BMC Immunol 11:52. https://doi.org/10.1186/1471-2172-11-52
Kurowska-Stolarska M et al (2009) IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol 183:6469–6477. https://doi.org/10.4049/jimmunol.0901575
Martinez FO et al (2013) Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences. Blood 121:e57–e69. https://doi.org/10.1182/blood-2012-06-436212
Kim EY et al (2008) Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat Med 14:633–640. https://doi.org/10.1038/nm1770
Girodet PO et al (2016) Alternative macrophage activation is increased in asthma. Am J Respir Cell Mol Biol 55:467–475. https://doi.org/10.1165/rcmb.2015-0295OC
Artis D, Spits H (2015) The biology of innate lymphoid cells. Nature 517:293–301. https://doi.org/10.1038/nature14189
Saenz SA, Noti M, Artis D (2010) Innate immune cell populations function as initiators and effectors in Th2 cytokine responses. Trends Immunol 31:407–413. doi:S1471-4906(10)00125-0 [pii] https://doi.org/10.1016/j.it.2010.09.001
Neill DR et al (2010) Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464:1367–1370. doi:nature08900 [pii] https://doi.org/10.1038/nature08900
Moro K et al (2010) Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463:540–544. doi:nature08636 [pii] https://doi.org/10.1038/nature08636
Barlow JL et al (2012) Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J Allergy Clin Immunol 129:191–198 e191–e194. doi:S0091-6749(11)01565-X [pii] https://doi.org/10.1016/j.jaci.2011.09.041
Yasuda K et al (2012) Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice. Proc Natl Acad Sci U S A 109:3451–3456. doi:1201042109 [pii] https://doi.org/10.1073/pnas.1201042109
Klein Wolterink RG et al (2012) Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma. Eur J Immunol 42:1106–1116. https://doi.org/10.1002/eji.201142018
Yang Q et al (2013) T cell factor 1 is required for group 2 innate lymphoid cell generation. Immunity 38:694–704. https://doi.org/10.1016/j.immuni.2012.12.003
Mjosberg JM et al (2011) Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 12:1055–1062. https://doi.org/10.1038/ni.2104
Smith SG et al (2016) Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia. J Allergy Clin Immunol 137:75–86.e78. https://doi.org/10.1016/j.jaci.2015.05.037
Yang Q et al (2016) Group 2 innate lymphoid cells mediate ozone-induced airway inflammation and hyperresponsiveness in mice. J Allergy Clin Immunol 137:571–578. https://doi.org/10.1016/j.jaci.2015.06.037
Monticelli LA et al (2016) Arginase 1 is an innate lymphoid-cell-intrinsic metabolic checkpoint controlling type 2 inflammation. Nat Immunol 17:656. https://doi.org/10.1038/ni.3421. https://www.nature.com/articles/ni.3421 – supplementary-information
Halim TY, Krauss RH, Sun AC, Takei F (2012) Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity 36:451–463. https://doi.org/10.1016/j.immuni.2011.12.020
Shen X et al (2018) Group-2 innate lymphoid cells promote airway hyperresponsiveness through production of VEGFA. J Allergy Clin Immunol https://doi.org/10.1016/j.jaci.2018.01.005
Possa SS, Leick EA, Prado CM, Martins MA, Tibério IFLC (2013) Eosinophilic inflammation in allergic asthma. Front Pharmacol 4:46. https://doi.org/10.3389/fphar.2013.00046
Saito T et al (1997) Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells. J Infect Dis 175:497–504
Cherry WB, Yoon J, Bartemes KR, Iijima K, Kita H (2008) A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J Allergy Clin Immunol 121:1484–1490. doi:S0091-6749(08)00719-7 [pii] https://doi.org/10.1016/j.jaci.2008.04.005
Wong CK, Cheung PF, Ip WK, Lam CW (2005) Interleukin-25-induced chemokines and interleukin-6 release from eosinophils is mediated by p38 mitogen-activated protein kinase, c-Jun N-terminal kinase, and nuclear factor-kappaB. Am J Respir Cell Mol Biol 33:186–194. doi:2005-0034OC [pii] https://doi.org/10.1165/rcmb.2005-0034OC
Pegorier S, Wagner LA, Gleich GJ, Pretolani M (2006) Eosinophil-derived cationic proteins activate the synthesis of remodeling factors by airway epithelial cells. J Immunol 177:4861–4869. doi:177/7/4861 [pii]
Laan M et al (1999) Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 162:2347–2352
Cromwell O et al (1992) Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1 beta and tumour necrosis factor-alpha. Immunology 77:330–337
Osterlund C, Gronlund H, Gafvelin G, Bucht A (2010) Non-proteolytic aeroallergens from mites, cat and dog exert adjuvant-like activation of bronchial epithelial cells. Int Arch Allergy Immunol 155:111–118. doi:000318743 [pii] https://doi.org/10.1159/000318743
McAllister F et al (2005) Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J Immunol 175:404–412
Churchill L, Friedman B, Schleimer RP, Proud D (1992) Production of granulocyte-macrophage colony-stimulating factor by cultured human tracheal epithelial cells. Immunology 75:189–195
Kim KC et al (1987) Human neutrophil elastase releases cell surface mucins from primary cultures of hamster tracheal epithelial cells. Proc Natl Acad Sci U S A 84:9304–9308
van Wetering S et al (2000) Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase. J Investig Med 48:359–366
Lefrancais E et al (2012) IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc Natl Acad Sci U S A 109:1673–1678. https://doi.org/10.1073/pnas.1115884109
Alves-Filho JC et al (2010) Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat Med 16:708–712. https://doi.org/10.1038/nm.2156
Hueber AJ et al (2011) IL-33 induces skin inflammation with mast cell and neutrophil activation. Eur J Immunol 41:2229–2237. https://doi.org/10.1002/eji.201041360
Wenzel SE et al (1997) Bronchoscopic evaluation of severe asthma. Am J Respir Crit Care Med 156:737–743. https://doi.org/10.1164/ajrccm.156.3.9610046
Fahy JV, Kim KW, Liu J, Boushey HA (1995) Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 95:843–852
Holgate ST (2011) The sentinel role of the airway epithelium in asthma pathogenesis. Immunol Rev 242:205–219. https://doi.org/10.1111/j.1600-065X.2011.01030.x
Allakhverdi Z et al (2007) Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med 204:253–258. https://doi.org/10.1084/jem.20062211
Allakhverdi, Z., Smith, D. E., Comeau, M. R. & Delespesse, G. (2007) Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J Immunol 179, 2051–2054, doi:179/4/2051 [pii]
Iikura M et al (2007) IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab Investig 87:971–978. doi:3700663 [pii] https://doi.org/10.1038/labinvest.3700663
Kohda F, Koga T, Uchi H, Urabe K, Furue M (2002) Histamine-induced IL-6 and IL-8 production are differentially modulated by IFN-gamma and IL-4 in human keratinocytes. J Dermatol Sci 28:34–41
Siracusa MC, Kim BS, Spergel JM, Artis D (2013) Basophils and allergic inflammation. J Allergy Clin Immunol 132:789–788. https://doi.org/10.1016/j.jaci.2013.07.046
Pecaric-Petkovic T, Didichenko SA, Kaempfer S, Spiegl N, Dahinden CA (2009) Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 113:1526–1534. doi:blood-2008-05-157818 [pii] https://doi.org/10.1182/blood-2008-05-157818
Schneider E et al (2009) IL-33 activates unprimed murine basophils directly in vitro and induces their in vivo expansion indirectly by promoting hematopoietic growth factor production. J Immunol 183:3591–3597. doi:jimmunol.0900328 [pii] https://doi.org/10.4049/jimmunol.0900328
Siracusa MC et al (2011) TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation. Nature 477:229–233. doi:nature10329 [pii] https://doi.org/10.1038/nature10329
Noti M et al (2013) Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis. Nat Med 19:1005–1013. https://doi.org/10.1038/nm.3281
Kepley CL, McFeeley PJ, Oliver JM, Lipscomb MF (2001) Immunohistochemical detection of human basophils in postmortem cases of fatal asthma. Am J Respir Crit Care Med 164:1053–1058. https://doi.org/10.1164/ajrccm.164.6.2102025
Terashima A et al (2008) A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity. J Exp Med 205:2727–2733. doi:jem.20080698 [pii] https://doi.org/10.1084/jem.20080698
Tupin E, Kinjo Y, Kronenberg M (2007) The unique role of natural killer T cells in the response to microorganisms. Nat Rev Microbiol 5:405–417. doi:nrmicro1657 [pii] https://doi.org/10.1038/nrmicro1657
Wingender G et al (2011) Invariant NKT cells are required for airway inflammation induced by environmental antigens. J Exp Med 208:1151–1162. https://doi.org/10.1084/jem.20102229
Nie H et al (2015) Invariant NKT cells act as an adjuvant to enhance Th2 inflammatory response in an OVA-induced mouse model of asthma. PLoS One 10:e0119901. https://doi.org/10.1371/journal.pone.0119901
Matangkasombut P et al (2008) Direct activation of natural killer T cells induces airway hyperreactivity in nonhuman primates. J Allergy Clin Immunol 121:1287–1289. https://doi.org/10.1016/j.jaci.2008.02.006
Akbari O et al (2006) CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N Engl J Med 354:1117–1129. https://doi.org/10.1056/NEJMoa053614
Vijayanand P et al (2007) Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. N Engl J Med 356:1410–1422. https://doi.org/10.1056/NEJMoa064691
Recaldin T, Fear DJ (2016) Transcription factors regulating B cell fate in the germinal centre. Clin Exp Immunol 183:65–75. https://doi.org/10.1111/cei.12702
Peled JU et al (2008) The biochemistry of somatic hypermutation. Annu Rev Immunol 26:481–511. https://doi.org/10.1146/annurev.immunol.26.021607.090236
van de Veen W et al (2016) Role of regulatory B cells in immune tolerance to allergens and beyond. J Allergy Clin Immunol 138:654–665. https://doi.org/10.1016/j.jaci.2016.07.006
Allakhverdi Z et al (2009) CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation. J Allergy Clin Immunol 123:472–478. doi:S0091-6749(08)01875-7 [pii] https://doi.org/10.1016/j.jaci.2008.10.022
Adcock IM, Caramori G, Chung KF (2008) New targets for drug development in asthma. Lancet 372:1073–1087. https://doi.org/10.1016/S0140-6736(08)61449-X
Chung KF (2011) p38 mitogen-activated protein kinase pathways in asthma and COPD. Chest 139:1470–1479. https://doi.org/10.1378/chest.10-1914
Van Raemdonck K, Van den Steen PE, Liekens S, Van Damme J, Struyf S (2015) CXCR3 ligands in disease and therapy. Cytokine Growth Factor Rev 26:311–327. https://doi.org/10.1016/j.cytogfr.2014.11.009
Proud D, Leigh R (2011) Epithelial cells and airway diseases. Immunol Rev 242:186–204. https://doi.org/10.1111/j.1600-065X.2011.01033.x
Spurrell JC, Wiehler S, Zaheer RS, Sanders SP, Proud D (2005) Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection. Am J Physiol Lung Cell Mol Physiol 289:L85–L95. https://doi.org/10.1152/ajplung.00397.2004
Terada N et al (2001) Expression of C-C chemokine TARC in human nasal mucosa and its regulation by cytokines. Clin Exp Allergy 31:1923–1931
Heijink IH et al (2007) Der p, IL-4, and TGF-beta cooperatively induce EGFR-dependent TARC expression in airway epithelium. Am J Respir Cell Mol Biol 36:351–359. https://doi.org/10.1165/rcmb.2006-0160OC
Panina-Bordignon P et al (2001) The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. J Clin Invest 107:1357–1364. https://doi.org/10.1172/JCI12655
Montes-Vizuet R et al (2006) CC chemokine ligand 1 is released into the airways of atopic asthmatics. Eur Respir J 28:59–67. https://doi.org/10.1183/09031936.06.00134304
O'Shea JJ, Paul WE (2010) Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 327:1098–1102. https://doi.org/10.1126/science.1178334
Taha R, Hamid Q, Cameron L, Olivenstein R (2003) T helper type 2 cytokine receptors and associated transcription factors GATA-3, c-MAF, and signal transducer and activator of transcription factor-6 in induced sputum of atopic asthmatic patients. Chest 123:2074–2082
Malik S et al (2017) Transcription factor Foxo1 is essential for IL-9 induction in T helper cells. Nat Commun 8:815. https://doi.org/10.1038/s41467-017-00674-6
Chang HS et al (2017) Neutrophilic inflammation in asthma: mechanisms and therapeutic considerations. Expert Rev Respir Med 11:29–40. https://doi.org/10.1080/17476348.2017.1268919
Valeri M, Raffatellu M (2016) Cytokines IL-17 and IL-22 in the host response to infection. Pathog Dis 74. https://doi.org/10.1093/femspd/ftw111
Boyman O et al (2015) EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders. Allergy 70:727–754. https://doi.org/10.1111/all.12616
Chung KF (2016) Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies. J Intern Med 279:192–204. https://doi.org/10.1111/joim.12382
Flayer CH, Haczku A (2017) The Th2 gene cluster unraveled: role of RHS6. Allergy 72:679–681. https://doi.org/10.1111/all.13130
Ansel KM, Djuretic I, Tanasa B, Rao A (2006) Regulation of Th2 differentiation and Il4 locus accessibility. Annu Rev Immunol 24:607–656. https://doi.org/10.1146/annurev.immunol.23.021704.115821
Dekker J, Marti-Renom MA, Mirny LA (2013) Exploring the three-dimensional organization of genomes: interpreting chromatin interaction data. Nat Rev Genet 14:390–403. https://doi.org/10.1038/nrg3454
Chatila TA, Li N, Garcia-Lloret M, Kim HJ, Nel AE (2008) T-cell effector pathways in allergic diseases: transcriptional mechanisms and therapeutic targets. J Allergy Clin Immunol 121:812–823.; quiz 824-815. https://doi.org/10.1016/j.jaci.2008.02.025
Wang C, Collins M, Kuchroo VK (2015) Effector T cell differentiation: are master regulators of effector T cells still the masters? Curr Opin Immunol 37:6–10. https://doi.org/10.1016/j.coi.2015.08.001
Lee GR, Kim ST, Spilianakis CG, Fields PE, Flavell RA (2006) T helper cell differentiation: regulation by cis elements and epigenetics. Immunity 24:369–379. https://doi.org/10.1016/j.immuni.2006.03.007
Mercer TR, Mattick JS (2013) Understanding the regulatory and transcriptional complexity of the genome through structure. Genome Res 23:1081–1088. https://doi.org/10.1101/gr.156612.113
Hwang SS, Jang SW, Lee KO, Kim HS, Lee GR (2016) RHS6 coordinately regulates the Th2 cytokine genes by recruiting GATA3, SATB1, and IRF4. Allergy. https://doi.org/10.1111/all.13078
Mohrs M et al (2001) Deletion of a coordinate regulator of type 2 cytokine expression in mice. Nat Immunol 2:842–847. https://doi.org/10.1038/ni0901-842
Lee GR, Fields PE, Griffin TJ, Flavell RA (2003) Regulation of the Th2 cytokine locus by a locus control region. Immunity 19:145–153
Lee GR, Fields PE, Flavell RA (2001) Regulation of IL-4 gene expression by distal regulatory elements and GATA-3 at the chromatin level. Immunity 14:447–459
Fields PE, Lee GR, Kim ST, Bartsevich VV, Flavell RA (2004) Th2-specific chromatin remodeling and enhancer activity in the Th2 cytokine locus control region. Immunity 21:865–876. https://doi.org/10.1016/j.immuni.2004.10.015
Koh BH et al (2010) Th2 LCR is essential for regulation of Th2 cytokine genes and for pathogenesis of allergic asthma. Proc Natl Acad Sci U S A 107:10614–10619. https://doi.org/10.1073/pnas.1005383107
Williams A et al (2013) Hypersensitive site 6 of the Th2 locus control region is essential for Th2 cytokine expression. Proc Natl Acad Sci U S A 110:6955–6960. https://doi.org/10.1073/pnas.1304720110
Zeng WP (2013) ‘All things considered’: transcriptional regulation of T helper type 2 cell differentiation from precursor to effector activation. Immunology 140:31–38. https://doi.org/10.1111/imm.12121
Kim K, Kim N, Lee GR (2016) Transcription factors Oct-1 and GATA-3 cooperatively regulate Th2 cytokine gene expression via the RHS5 within the Th2 locus control region. PLoS One 11:e0148576. https://doi.org/10.1371/journal.pone.0148576
Hwang SS, Jang SW, Lee GR (2017) RHS6-mediated chromosomal looping and nuclear substructure binding is required for Th2 cytokine gene expression. Biochim Biophys Acta 1860:383–391. https://doi.org/10.1016/j.bbagrm.2017.01.008
Hwang SS, Jang SW, Lee KO, Kim HS, Lee GR (2017) RHS6 coordinately regulates the Th2 cytokine genes by recruiting GATA3, SATB1, and IRF4. Allergy 72:772–782. https://doi.org/10.1111/all.13078
Zhu J (2010) Transcriptional regulation of Th2 cell differentiation. Immunol Cell Biol 88:244–249. https://doi.org/10.1038/icb.2009.114
Burute M, Gottimukkala K, Galande S (2012) Chromatin organizer SATB1 is an important determinant of T-cell differentiation. Immunol Cell Biol 90:852–859
Accordini S et al (2016) An interleukin 13 polymorphism is associated with symptom severity in adult subjects with ever asthma. PLoS One 11:e0151292. https://doi.org/10.1371/journal.pone.0151292
Schieck M et al (2014) A polymorphism in the TH 2 locus control region is associated with changes in DNA methylation and gene expression. Allergy 69:1171–1180. https://doi.org/10.1111/all.12450
Sharma V et al (2014) Fine-mapping of IgE-associated loci 1q23, 5q31, and 12q13 using 1000 Genomes Project data. Allergy 69:1077–1084. https://doi.org/10.1111/all.12431
Slifka MK, Amanna I (2014) How advances in immunology provide insight into improving vaccine efficacy. Vaccine 32:2948–2957. https://doi.org/10.1016/j.vaccine.2014.03.078
Killingbeck SS, Ge MQ, Haczku A (2017) Patching it together: epicutaneous vaccination with heat-labile Escherichia coli toxin against birch pollen allergy. Allergy 72:5–8. https://doi.org/10.1111/all.13064
Levitz SM (2016) Aspergillus vaccines: Hardly worth studying or worthy of hard study? Med Mycol. https://doi.org/10.1093/mmy/myw081
Calderon MA et al (2013) Allergen immunotherapy: a new semantic framework from the European Academy of Allergy and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL consensus report. Allergy 68:825–828
Akdis M, Akdis CA (2014) Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. J Allergy Clin Immunol 133:621–631. https://doi.org/10.1016/j.jaci.2013.12.1088
Larche M, Akdis CA, Valenta R (2006) Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 6:761–771. https://doi.org/10.1038/nri1934
Curtis HH (1902) The Immunization Treatment of Hay Fever. JAMA XXXIX(20):1267–1268. doi:10.1001/jama.1902.02480460045013
Bachmann MF, Kundig TM (2016) Allergen specific immunotherapy: is it vaccination against toxins after all? Allergy. https://doi.org/10.1111/all.12890
Tam HH et al (2016) Specific allergen immunotherapy for the treatment of atopic eczema: a Cochrane systematic review. Allergy 71:1345–1356. https://doi.org/10.1111/all.12932
Jutel M, Kosowska A, Smolinska S (2016) Allergen immunotherapy: past, present, and future. Allergy, Asthma Immunol Res 8:191–197. https://doi.org/10.4168/aair.2016.8.3.191
Assa'ad A (2009) Eosinophilic gastrointestinal disorders. Allergy Asthma Proc 30:17–22. https://doi.org/10.2500/aap.2009.30.3189
Nelson HS (2016) Allergen immunotherapy now and in the future. Allergy Asthma Proc 37:268–272. https://doi.org/10.2500/aap.2016.37.3966
Burks AW et al (2013) Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. J Allergy Clin Immunol 131:1288–1296. e1283. https://doi.org/10.1016/j.jaci.2013.01.049
Canonica GW et al (2016) Therapeutic interventions in severe asthma. World Allergy Organ J 9:40. https://doi.org/10.1186/s40413-016-0130-3
Akdis M et al (2016) Interleukins (from IL-1 to IL-38), interferons, transforming growth factor beta, and TNF-alpha: receptors, functions, and roles in diseases. J Allergy Clin Immunol. https://doi.org/10.1016/j.jaci.2016.06.033
van der Neut Kolfschoten M et al (2007) Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 317:1554–1557. https://doi.org/10.1126/science.1144603
Ozdemir C, Kucuksezer UC, Akdis M, Akdis CA (2016) Mechanisms of aeroallergen immunotherapy: subcutaneous immunotherapy and sublingual immunotherapy. Immunol Allergy Clin N Am 36:71–86. https://doi.org/10.1016/j.iac.2015.08.003
Rosser EC, Mauri C (2015) Regulatory B cells: origin, phenotype, and function. Immunity 42:607–612. https://doi.org/10.1016/j.immuni.2015.04.005
Behrens RH et al (2014) Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala. Lancet Infect Dis 14:197–204. https://doi.org/10.1016/S1473-3099(13)70297-4
Ma Y (2016) Recent advances in nontoxic Escherichia coli heat-labile toxin and its derivative adjuvants. Expert Rev Vaccines:1–11. https://doi.org/10.1080/14760584.2016.1182868
da Hora VP, Conceicao FR, Dellagostin OA, Doolan DL (2011) Non-toxic derivatives of LT as potent adjuvants. Vaccine 29:1538–1544. https://doi.org/10.1016/j.vaccine.2010.11.091
Liang S, Hajishengallis G (2010) Heat-labile enterotoxins as adjuvants or anti-inflammatory agents. Immunol Investig 39:449–467
El-Kassas S et al (2015) Cell clustering and delay/arrest in T-cell division implicate a novel mechanism of immune modulation by E. coli heat-labile enterotoxin B-subunits. Cell Immunol 295:150–162. https://doi.org/10.1016/j.cellimm.2015.02.014
Cabauatan CR et al (2017) Heat-labile Escherichia coli toxin enhances the induction of allergen-specific IgG antibodies in epicutaneous patch vaccination. Allergy 72:164–168. https://doi.org/10.1111/all.13036
Valenta R, Campana R, Focke-Tejkl M, Niederberger V (2016) Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: lessons from the past and novel mechanisms of action for the future. J Allergy Clin Immunol 137:351–357. https://doi.org/10.1016/j.jaci.2015.12.1299
Palucka K, Banchereau J, Mellman I (2010) Designing vaccines based on biology of human dendritic cell subsets. Immunity 33:464–478. https://doi.org/10.1016/j.immuni.2010.10.007
Zaleska A et al (2014) Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccine. Allergy 69:1162–1170. https://doi.org/10.1111/all.12461
Lin CY et al (2015) Biodegradable polymeric microsphere-based vaccines and their applications in infectious diseases. Hum Vaccin Immunother 11:650–656. https://doi.org/10.1080/21645515.2015.1009345
Cabauatan CR et al (2016) Heat-labile Escherichia coli toxin enhances the induction of allergen-specific IgG antibodies in epicutaneous patch vaccination. Allergy. https://doi.org/10.1111/all.13036
Lin CH, Cheng SL (2016) A review of omalizumab for the management of severe asthma. Drug Des Devel Ther 10:2369–2378. https://doi.org/10.2147/DDDT.S112208
Chang TW et al (2015) The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria. J Allergy Clin Immunol 135:337–342. https://doi.org/10.1016/j.jaci.2014.04.036
Chang TW, Shiung YY (2006) Anti-IgE as a mast cell-stabilizing therapeutic agent. J Allergy Clin Immunol 117:1203–1212.; quiz 1213. https://doi.org/10.1016/j.jaci.2006.04.005
Ortega HG et al (2014) Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med 371:1198–1207. https://doi.org/10.1056/NEJMoa1403290
Bel EH et al (2014) Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma. N Engl J Med 371:1189–1197. https://doi.org/10.1056/NEJMoa1403291
Tan LD, Bratt JM, Godor D, Louie S, Kenyon NJ (2016) Benralizumab: a unique IL-5 inhibitor for severe asthma. J Asthma Allergy 9:71–81. https://doi.org/10.2147/JAA.S78049
Varricchi G, Bagnasco D, Borriello F, Heffler E, Canonica GW (2016) Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders: evidence and unmet needs. Curr Opin Allergy Clin Immunol 16:186–200. https://doi.org/10.1097/ACI.0000000000000251
Wang FP, Liu T, Lan Z, Li SY, Mao H (2016) Efficacy and safety of anti-interleukin-5 therapy in patients with asthma: a systematic review and meta-analysis. PLoS One 11:e0166833. https://doi.org/10.1371/journal.pone.0166833
Antoniu SA (2017) Benralizumab as a potential treatment of asthma. Expert Opin Biol Ther:1–6. https://doi.org/10.1080/14712598.2017.1319471
Cabon Y et al (2017) Comparison of anti-interleukin-5 therapies in patients with severe asthma: global and indirect meta-analyses of randomized placebo-controlled trials. Clin Exp Allergy 47:129–138. https://doi.org/10.1111/cea.12853
Ferguson GT et al (2017) Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med. https://doi.org/10.1016/S2213-2600(17)30190-X
Nair P et al (2017) Oral glucocorticoid-sparing effect of benralizumab in severe asthma. N Engl J Med. https://doi.org/10.1056/NEJMoa1703501
Nair P et al (2009) Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 360:985–993. https://doi.org/10.1056/NEJMoa0805435
Pavord ID et al (2012) Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet 380:651–659. https://doi.org/10.1016/S0140-6736(12)60988-X
Ortega H et al (2014) Cluster analysis and characterization of response to mepolizumab. A step closer to personalized medicine for patients with severe asthma. Ann Am Thorac Soc 11:1011–1017. https://doi.org/10.1513/AnnalsATS.201312-454OC
Leonard WJ (2002) TSLP: finally in the limelight. Nat Immunol 3:605–607. https://doi.org/10.1038/ni0702-605
Corren J et al (2017) Tezepelumab in adults with uncontrolled asthma. N Engl J Med 377:936–946. https://doi.org/10.1056/NEJMoa1704064
Kuo CS et al (2017) T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED. Eur Respir J 49. https://doi.org/10.1183/13993003.02135-2016
Mitchell PD, O’Byrne PM (2017) Epithelial-derived cytokines in asthma. Chest 151:1338–1344. https://doi.org/10.1016/j.chest.2016.10.042
Mitchell PD, O'Byrne PM (2017) Biologics and the lung: TSLP and other epithelial cell-derived cytokines in asthma. Pharmacol Ther 169:104–112. https://doi.org/10.1016/j.pharmthera.2016.06.009
Striz I (2017) Cytokines of the IL-1 family: recognized targets in chronic inflammation underrated in organ transplantations. Clin Sci (Lond) 131:2241–2256. https://doi.org/10.1042/CS20170098
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Flayer, C.H., Killingbeck, S.S., Larson, E., Allakhverdi, Z., Haczku, A. (2018). Adaptive Immunity of Airway Inflammation in Asthma. In: Riccardi, C., Levi-Schaffer, F., Tiligada, E. (eds) Immunopharmacology and Inflammation. Springer, Cham. https://doi.org/10.1007/978-3-319-77658-3_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-77658-3_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-77657-6
Online ISBN: 978-3-319-77658-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)